Physician profile
Joseph Sonstein
NPI 1134323728
$8,262.95
in general payments reported to CMS, 2019-2025
14 companies · $5,083 in 2025
The $5,083 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $2,142 · 2022: $220 · 2023: $57.69 · 2024: $41.46 · 2025: $5,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $434 · Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $434.19 |
| Food and Beverage | $248.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,108.49 | 2020-2025 | |
| Boston Scientific Corporation | $302.29 | 2019-2025 | General - Erectile Dysfunction, Moses 550 Dfl |
| Cook Medical LLC | $195.95 | 2019 | |
| Coloplast Corp | $160.85 | 2022 | |
| Neotract INC. | $147.36 | 2019 | |
| Teleflex LLC | $105.77 | 2019-2022 | |
| Astellas Pharma US INC | $62.95 | 2019 | |
| Healthtronics Stone Solutions, LLC | $56.59 | 2020 | |
| Convatec INC. | $30.45 | 2023 | |
| Urogen Pharma, INC. | $27.24 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $24.30 | 2022 | |
| Olympus America INC. | $13.94 | 2024 | Itind System |
| Axonics, INC. | $13.61 | 2024 | Axonics |
| Endo Pharmaceuticals INC. | $13.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sonstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.